Position in BNTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$42,876,686
-$21,922,998 QoQ
Shares Held
482,411
-29.1% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94.72006235347038.ToString("F0")%
Shared 0.ToString("F0")%
None 5.2799376465296195.ToString("F0")%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. BNTX ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in BNTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,876,686 | 482,411 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $64,799,684 | 680,669 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $59,469,435 | 603,016 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $61,187,453 | 574,692 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $64,980,958 | 713,606 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $84,708,487 | 743,383 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $80,278,538 | 675,916 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $92,236,962 | 1,147,797 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $99,990,693 | 1,083,910 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $66,305,605 | 628,251 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $63,088,330 | 580,710 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $61,544,705 | 570,228 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $119,401,337 | 958,508 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $67,429,398 | 448,871 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $45,943,766 | 340,627 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $40,957,170 | 274,696 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $50,427,938 | 295,661 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $73,812,006 | 286,315 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $91,360,742 | 334,667 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $71,769,657 | 320,572 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $52,061,463 | 476,797 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $25,203,618 | 309,171 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $6,877,029 | 99,336 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,548,701 | 23,205 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $797,276 | 13,652 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||